Disclaimer: These presentation papers are provided on the ODC's website solely for the purpose of indicating or suggesting what ODC representatives spoke about to the various conferences and seminars to which it relates. The papers are not legislative in nature and should not be taken to be statements of any law or policy in any way. The Australian Government Department of Health (of which the ODC is a part) advises that (a) the presentation papers should not be relied upon in any way as representing a comprehensive description of regulatory requirements, and (b) cannot guarantee, and assumes no legal liability or responsibility for, the accuracy, currency or completeness of the information contained in the presentation paper.
- Presented by: George Masri, Assistant Secretary, Regulatory Services and Drug Control Branch, Regulatory Practice and Support Division, Department of Health
- Presented at: Webinar
- Presentation date: 4 November 2020